Other search tools

About this data

The publication data currently available has been vetted by Vanderbilt faculty, staff, administrators and trainees. The data itself is retrieved directly from NCBI's PubMed and is automatically updated on a weekly basis to ensure accuracy and completeness.

If you have any questions or comments, please contact us.

Results: 1 to 9 of 9

Publication Record

Connections

Combined Angiotensin Receptor Antagonism and Neprilysin Inhibition.
Hubers SA, Brown NJ
(2016) Circulation 133: 1115-24
MeSH Terms: Abnormalities, Drug-Induced, Aminobutyrates, Angioedema, Angiotensin Receptor Antagonists, Biphenyl Compounds, Bradykinin, Contraindications, Drug Combinations, Drug Costs, Drug Synergism, Enalapril, Enzyme Inhibitors, Female, Follow-Up Studies, Heart Failure, Humans, Hyperkalemia, Hypertension, Kidney, Multicenter Studies as Topic, Natriuretic Peptides, Neprilysin, Pregnancy, Prodrugs, Prospective Studies, Pyridines, Randomized Controlled Trials as Topic, Stroke Volume, Tetrazoles, Thiazepines, Valsartan
Added April 6, 2017
0 Communities
1 Members
0 Resources
31 MeSH Terms
Ethical considerations for the clinical oncologist in an era of oncology drug shortages.
Jagsi R, Spence R, Rathmell WK, Bradbury A, Peppercorn J, Grubbs S, Moy B
(2014) Oncologist 19: 186-92
MeSH Terms: Antineoplastic Agents, Child, Drug Costs, Female, Health Care Rationing, Humans, Medical Oncology, Middle Aged, Neoplasms, Physicians, United States
Added October 17, 2015
0 Communities
1 Members
0 Resources
11 MeSH Terms
Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.
Shepardson D, Marks SM, Chesson H, Kerrigan A, Holland DP, Scott N, Tian X, Borisov AS, Shang N, Heilig CM, Sterling TR, Villarino ME, Mac Kenzie WR
(2013) Int J Tuberc Lung Dis 17: 1531-7
MeSH Terms: Antitubercular Agents, Computer Simulation, Cost-Benefit Analysis, Directly Observed Therapy, Drug Administration Schedule, Drug Costs, Drug Therapy, Combination, Hospital Costs, Humans, Isoniazid, Latent Tuberculosis, Models, Economic, Quality-Adjusted Life Years, Rifampin, Time Factors, Treatment Outcome, United States
Added May 29, 2014
0 Communities
1 Members
0 Resources
17 MeSH Terms
New insights into the role of anabolic interventions in dialysis patients with protein energy wasting.
Dong J, Ikizler TA
(2009) Curr Opin Nephrol Hypertens 18: 469-75
MeSH Terms: Anabolic Agents, Combined Modality Therapy, Cost Savings, Cost-Benefit Analysis, Drug Costs, Enteral Nutrition, Hospital Costs, Humans, Parenteral Nutrition, Protein-Energy Malnutrition, Renal Dialysis, Resistance Training, Treatment Outcome
Added September 29, 2014
0 Communities
1 Members
0 Resources
13 MeSH Terms
Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications.
Bakaeen F, Rice D, Correa AM, Walsh GL, Vaporciyan AA, Putnam JB, Swisher SG, Roth JA, Huh J, Chu D, Smythe WR
(2007) Ann Thorac Surg 84: 982-6
MeSH Terms: Aged, Aprotinin, Blood Transfusion, Drug Costs, Female, Hemostasis, Hemostatics, Humans, Incidence, Male, Middle Aged, Pneumonectomy, Postoperative Complications, Retrospective Studies
Added March 27, 2014
0 Communities
1 Members
0 Resources
14 MeSH Terms
Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer.
Lloyd A, Penson D, Dewilde S, Kleinman L
(2008) Prostate Cancer Prostatic Dis 11: 153-9
MeSH Terms: Adenocarcinoma, Aged, Androgen Antagonists, Anilides, Antineoplastic Agents, Hormonal, Choice Behavior, Cross-Sectional Studies, Diarrhea, Drug Administration Schedule, Drug Costs, Drug Therapy, Erectile Dysfunction, Flutamide, Gynecomastia, Health Surveys, Hematuria, Humans, Life Expectancy, Male, Middle Aged, Nitriles, Patient Acceptance of Health Care, Patient Satisfaction, Prostatic Neoplasms, Tosyl Compounds
Added March 5, 2014
0 Communities
1 Members
0 Resources
25 MeSH Terms
Docetaxel in non-small cell lung cancer: impact on quality of life and pharmacoeconomics.
Horn L, Visbal A, Leighl NB
(2007) Drugs Aging 24: 411-28
MeSH Terms: Aged, Antineoplastic Agents, Carcinoma, Non-Small-Cell Lung, Clinical Trials as Topic, Docetaxel, Drug Costs, Humans, Lung Neoplasms, Quality of Life, Taxoids, Treatment Outcome
Added June 26, 2014
0 Communities
1 Members
0 Resources
11 MeSH Terms
Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia.
Stringer EM, Sinkala M, Stringer JS, Mzyece E, Makuka I, Goldenberg RL, Kwape P, Chilufya M, Vermund SH
(2003) AIDS 17: 1377-82
MeSH Terms: Antiviral Agents, Cost-Benefit Analysis, Counseling, Developing Countries, Drug Costs, Female, HIV Infections, Humans, Infant, Newborn, Infectious Disease Transmission, Vertical, Male, Nevirapine, Patient Compliance, Pregnancy, Pregnancy Complications, Infectious, Urban Health, Zambia
Added March 5, 2014
0 Communities
1 Members
0 Resources
17 MeSH Terms
Perinatal HIV transmission: developing country considerations.
Goldenberg RL, Stringer JS, Sinkala M, Vermund SH
(2002) J Matern Fetal Neonatal Med 12: 149-58
MeSH Terms: Anti-HIV Agents, Breast Feeding, Developing Countries, Drug Costs, Female, HIV Infections, Humans, Infectious Disease Transmission, Vertical, Pregnancy, Pregnancy Complications, Infectious
Added March 5, 2014
0 Communities
1 Members
0 Resources
10 MeSH Terms